Department of Radiology

2018: 24th Annual Canadian Preparation and Review Course in Clinical and Radiation Oncology

2018: 24th Annual Canadian Preparation and Review Course in Clinical and Radiation Oncology

Declaration of Conflict of Interest

The University of Ottawa, Office of Continuing Professional Development (OCPD) requires that all presenters and members of the planning committee complete a Disclosure of Conflict of Interest (COI) form. The 2007 CMA Guidelines for Physicians in Interaction with Industry, Section 24, states: 

“CME/CPD organizers and individual physician presenters are responsible for ensuring the scientific validity, objectivity and completeness of CME/CPD activities. Organizers and individual presenters must disclose to the participants at their CME/CPD events any financial affiliations with manufacturers of products mentioned at the event or with manufacturers of competing products.”

This serves as the basis for the University of Ottawa’s Conflict of Interest policies, and is adapted from the Royal College and the College of Family Physicians of Canada forms. The intent of this policy is not to prohibit speakers from presenting, but rather to inform the audience of any bias that speakers may have.

Faculty Bios

Graham Cook, MD, FRCPC. Co-Course Director

Dr. Cook is a Radiation Oncologist Staff at the Ottawa Hospital. He went to Memorial University  for Medical School and Ottawa for his Residency. Dr. Cook also completed a Fellowship in Ablative Radiotherapy. Dr. Cook's focus is on Thoracic Malignancies & Sarcoma and Derm.

Disclosures:

This individual has indicated they have no commercial nor financial interests to disclose. 

Jean-Marc Bourque, MD MScPH FRCPC- Co Course Director

Dr. Jean-Marc Bourque studied medicine at l’Université de Montréal and radiation oncology at Western University, while also completing a 2-year Global Health Certificate at the Dalla Lana School of Public Health at the University of Toronto.

He was the recipient of the CARO-Elekta Fellowship Award and the Royal College Detweiler Award to do a 2-year academic fellowship at the Institute of Cancer Policy at Kings College London while concurrently completing a M Sc. in Public Health at the London School of Hygiene and Tropical Medicine in the UK.

Dr. Bourque is now working as a  staff radiation oncologist at The Ottawa Hospital and continues to do consultancy work for the United Nations and collaborations with the World Health Organization in work relating to Global Oncology.

Disclosures:

This individual has report they have no financial or commercial interests to disclose.

Kristopher Dennis, MD, FRCPC, PhD

 

Dr. Dennis is a staff at the Ottawa Hospital and an Associate Professor at the University of Ottawa. Dr. Dennis has a clinical and research focus on palliative radiotherapy, symptom control and gastrointestinal malignancies.

Disclosures:

This individual reported that s/he does not have any financial relationships with any commercial interest.

Rajiv Samant, MD

 

Dr. R. Samant, Graduated from Dalhousie University Medical School in Halifax year 1988.  Residency in Radiation Oncology at the Ottawa Hospital Cancer Centre 1989 - 1993.  Worked at several Cancer Centres across the country including St. John’s (Newfoundland), Surrey (British Columbia), Sudbury (Ontario) before returning to Ottawa in year 2001.  Currently a radiation oncologist at the Ottawa Hospital Cancer Centre and an Associate Professor in the Faculty of Medicine at the University of Ottawa.  Areas of clinical interest include Gynaecology and Hematologic malignancies as well as the role of radiotherapy in palliative care.  Has a major interest in medical education, shared decision making and improving radiotherapy knowledge among non-oncology health care professionals.

Disclosures:

This individual has reported they have no financial or commercial interests to declare

Garth Nicholas, MD

Choan, E, MD

Dr. Choan E is a staff Radiation Oncologist at the Ottawa hospital and a faculty member at the University of Ottawa.

Disclosures:

TBD

Colin Brown, MD

Dr. Brown is currently a Clinical Fellow in Radiation Oncology at The Ottawa Hospital Cancer Centre focusing on GI and CNS malignancies including SRS. He completed his residency at the University of Ottawa in 2013, successfully completed the Royal College examination and obtained his FRCPC certification.

Disclosures:

This individual has indicated they have no financial or commercial interests to disclose

Lesley Buckley, MSc, PhD

 

Dr Buckley is a clinical medical physicist and radiation safety officer at The Ottawa Hospital Cancer Centre. She has a BSc in physics from McGill University and completed her graduate studies in medical physics at the University of Wisconsin (MSc) and at Carleton University (PhD). She is certified in both radiation oncology physics and diagnostic imaging physics by the Canadian College of Physicists in Medicine. Her clinical interests include improving the use of imaging in radiation therapy and she is actively involved in training and education initiatives within the radiation medicine program. 

Disclosures:

This individual has indicated that s/he has no financial or commercial interest to disclose

Laval Grimard, MD

 

 Dr. Grimard is a Staff Radiation Oncologist at the Ottawa Hospital.

Peter Cross, MD

Krystine Lupe, MD

Dr. Kystine Lupe Radiation Oncologist, joined the Division of Radiation Oncology at The Ottawa Hospital July 2010.  Dr. Lupe is a Fellow of the Royal College of Physicians and Surgeons of Canada.  She completed her residency training in Radiation Oncology at the University of Western Ontario and subsequently completed a Fellowship with a focus on breast and gynecologic malignancies the BC Cancer Agency, Vancouver Island Centre.   During this time she combined clinical service with research focused on breast cancer outcomes and brachytherapy for gynaecologic malignancies.

Disclosures:

This individual has reported they have no financial or commercial interests to disclose.

Marc Gaudet, MD

Originally from Moncton New Brunswick, Dr Gaudet completed medical school and residency training at Laval University in Quebec City.  During his residency he completed a Masters in Clinical Epidemiology from Laval University and the Royal College of Physicians and Surgeons of Canada’s Clinician Investigator Program.  He then completed his clinical research fellowship at BCCA Vancouver as well as a Masters in Health Administration from the University of British Columbia.  He served as a staff radiation oncologist, head of radiation oncology and director of oncology research at the Gatineau Hospital from 2013 to 2016 and then moved on to a position at The Ottawa Hospital in June 2016 where he specializes in He specializes in GYN, Head and Neck and GI malignancies.  He is currently an Assistant Professor of Radiation Oncology at the University of Ottawa and a Senior Clinician Investigator with the Clinical Epidemiology Program of the Ottawa Hospital Research Institute.  He also currently serves as president of the Canadian Brachytherapy Group and and Medical Examiner of complaints for the CISSS de l’Outaouais.  His current Research Interests include inequalities in access to cancer care, cost-effectiveness of cancer care and brachytherapy.

Disclosures:

Nature of affiliation

For-profit or not-for-profit organization(s)

Description of affiliation

Member of an advisory board or speakers’ bureau.

Merck

Advisory Board

Alain Haddad, MD, FRCPC

Dr. Haddad is a staff Radiation Oncologist at the Ottawa hospital and faculty at the University of Ottawa.

Disclosures:

This individual has indicated they have do financial or commercial interests to disclose.

 

Wayne Kendal, MD

Scott Morgan, MD

 

Dr. Morgan is a radiation oncologist at The Ottawa Hospital Cancer Centre and an Assistant Professor at the University of Ottawa. He holds degrees in engineering physics from UBC, medicine from Queen’s University, and an MSc in Clinical Trials from the University of London. Prior to starting his practice in Ottawa in 2010, he completed a fellowship in genitourinary clinical oncology at The Royal Marsden Hospital in London. His practice is focused on genitourinary and breast malignancy. Since 2016, he has served as Co-Chair of the Genitourinary Guideline Advisory Group of the American Society of Clinical Oncology.

Disclosures:

This individual has indicated they have the following disclosure:

Nature of affiliation

For-profit or not-for-profit organization(s)

Description of affiliation

Member of an advisory board or speakers’ bureau.

Astellas, Bayer, Janssen

Advisory Board/Consultant

Currently participating, or have participated, in a clinical trial within the past two years.

Janssen

 

Bayer

Co-investigator, ATLAS and LATITUDE trials

Co-investigator, ERA-223 trial

Jason Pantarotto, MD, FRCPC

 

Head, Radiation Medicine Program, The Ottawa Hospital Cancer Centre, Associate Professor, Department of Radiology, Faculty of Medicine, University of Ottawa, Regional Radiotherapy Lead for Champlain Local health Integrated Network, Ontario 

Dr. Jason R. Pantarotto is Head of the Radiation Medicine Program at The Ottawa Hospital and Division Head for Radiation Oncology at the University of Ottawa. His education includes a degree in Applied Science from Queen’s University, a medical degree from Western University, a residency in Radiation Oncology from the University of Ottawa and a fellowship at the VU University Medical Centre in Amsterdam, The Netherlands. He joined The Ottawa Hospital in 2008 and is an Associate Professor.

Dr. Pantarotto has published on ablative radiotherapy for chest and abdominal tumours, advanced radiotherapy techniques for moving targets and factors related to process flow within radiation medicine. He has been an active participant in transforming cancer care in Ottawa since 2013, with a focus on lung cancer process flow. Dr. Pantarotto is a graduate of the Physician Leadership Development Program at the Schulich School of Business.

Disclosures:

 

 

Jean-Michel Caudrelier, MD

Dr. Jean-Michel Caudrelier is a staff Radiation Oncologist with the Ottawa hospital and a faculty member with the University of Ottawa.

Disclosures:

This individual has indicated they have no financial or commercial interests to disclose.

Christina Canil, MD, FRCPC

Dr. Canil completed medical school and her internal medicine residency at the University of Toronto and her medical oncology residency at McMaster University in Hamilton, Ontario. Dr. Canil went on to complete a two-year clinical research fellowship at the Princess Margaret Hospital in Toronto, with a focus on Genitourinary cancer. Dr. Canil’s research interests include drug development and survivorship in Genitourinary Cancer.  She is a member of the Ontario Provincial Program in Evidence-based Care for the Genitourinary Cancer Disease Site Group.  Dr. Canil also serves as the Chair of the Medical Advisory Board for Kidney Cancer Canada – a patient advocacy group for Canadians diagnosed with kidney cancer.

Disclosures:

Gosia Niedbala, BSc, MSc, PhD

 

Dr. Gosia Niedbala received a BSc in physics from University of Waterloo in Waterloo, Ontario in 1995.  She went on to earn her MSc (1998) and PhD (2004) in medical physics from Carleton University in Ottawa, with her specialty in the area of radiobiology.  Dr. Niedbala did her residency in medical physics at the Ottawa Hospital Cancer Centre from 2004-2007) and was hired as a medical physicist at this institution.  In addition to providing clinical support, she has been involved in teaching radiobiology to radiation oncology and nuclear medicine residents, as well as Carleton University graduate students, since 2008.  Her areas of research interest are in radiobiology, total marrow irradiation, and clinical medical physics

 Disclosures:

This individual reported that s/he does not have any financial relationships with any commercial interest.

Derek Tsang, MD

 

 Dr. Derek Tsang is an Assistant Professor in the Department of Radiation Oncology at the University of Toronto. He is a board-certified radiation oncologist who works at the Princess Margaret Cancer Centre and Hospital for Sick Children. He attained his medical training at Queen’s University in 2011, followed by residency training in radiation oncology at the University of Toronto. Subsequently, he completed fellowship training in paediatric radiation oncology at St. Jude Children’s Research Hospital and completed a Masters’ degree in clinical epidemiology at the Harvard T.H. Chan School of Public Health. He is a member of the paediatric and adult central nervous system (CNS) tumour site groups at Princess Margaret, where he treats paediatric brain tumours, solid tumours, and haematologic malignancies.

Disclosures:

This individual has indicated they have the following disclosures:

Nature of affiliation: For-profit or not-forprofit organization(s) Description of affiliation Member of an advisory board or speakers’ bureau.   

  • Received payment from an organization (including gifts or other consideration, or in-kind compensation). Varian, RaySearch, IBA, Mevion, ProTom, Hitachi (for-profit)
  • Co-chair of a provincial symposium on proton therapy that received unrestricted sponsorship funds from these entities (2018) 

Nature of affiliation: Received/will receive a grant or an honorarium from a for-profit or not-for profit organization. 

  • Patient and Family Advisory Committee, Pencer Brain Tumour Centre, Princess Margaret Cancer Centre (not-for-profit) 
  •  Research Grant Funding (2018)   Audrey Meyer Mars International Fellowship in Clinical Oncology (2016) 

 

  

 

Nelson Miksys, PhD

 

Nelson is a radiation oncology medical physicist at The Ottawa Hospital Cancer Centre (TOHCC), with a specialization in stereotactic ablative external beam therapy. Before his clinical role, Nelson completed his radiation oncology medical physics residency at TOHCC, and before this, a PhD in medical physics from Carleton University, with research focused on Monte Carlo dose calculations for permanent implant prostate brachytherapy.

Disclosures:

This individual has reported they have no financial or commercial interests to disclose

Jeffrey Q. Cao, BSc (Hons), MD, MBA, FRCPC

Dr. Jeff Cao graduated from medical school at the University of Alberta followed by residency at Western University while earning his MBA at the Ivey School of Business. He completed his CARO Elekta Fellowship at the BC Cancer Agency in Vancouver and CPQR Fellowship with the Canadian Partnership for Quality Radiotherapy. Dr. Cao is currently a Radiation Oncologist at the London Regional Cancer Program treating breast, hematologic, and hepatobiliary malignancies. He is also Chair of the CARO Communications Committee and Treasurer for the Canadian Radiation Oncology Foundation.

Disclosures:

Khalil Sultanem, MD, FRCP

 

Dr. Khalil Sultanem completed his Doctor of Medicine at Université de Sherbrooke and his residency at McGill University.  He also completed a fellowship at the University of California, San Francisco.  He is a member of the Sir Mortimer B. Davis Jewish General Hospital’s Oncology Department, Division of Radiation Oncology.  Dr. Sultanem is Assistant Professor at McGill University where he is also Site Director of the Undergraduate Oncology Program.    He also holds the position of Director of l’Assocation des Radio-oncologues du Québec.  

Disclosures:

Chia-Lin (Eric) Tseng, MD

  

Dr. Chia-Lin (Eric) Tseng is an Assistant Professor at the University of Toronto, Department of Radiation Oncology and a staff Radiation Oncologist at Sunnybrook Health Sciences Centre, Odette Cancer Centre.  His clinical focus is in the treatment of central nervous system (CNS) and genitourinary (GU) tumours. He is involved in MR-linac technology at Sunnybrook and is interested in novel technologies for CNS cancers and brachytherapy for GU cancers.  His research focuses on the applications of the MR-linac for CNS patients, its dosimetric implications, and streamlining MR-guided radiotherapy using an MR-only workflow.  Within CNS, Dr. Tseng has a particular research interest in spine stereotactic body radiotherapy (SBRT), glioma treatment, and stereotactic radiosurgery for brain metastases.

Disclosures:

Currently participating, or have participated, in a clinical trial within the past two years:NRG Oncology,Canadian Cancer Trials Group,RTOG Foundation Inc,Sunnybrook Health Sciences CentreParticipation on clinical trials as primary investigator, local primary investigator, or sub-Investigator,